Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes

被引：82
作者：
Harenberg, J [1 ]
机构：
[1] Univ Hosp, Dept Internal Med & Geriatr, Mannheim, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 04期
关键词：
D O I：
10.1111/j.1538-7933.2004.00647.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：547 / 550
页数：4
相关论文
共 27 条
  • [1] ALHENCGELAS M, 1994, THROMB HAEMOSTASIS, V71, P698
  • [2] LOW-MOLECULAR-WEIGHT HEPARIN(S)
    BARROWCLIFFE, TW
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (01) : 1 - 7
  • [3] Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes
    Becker, RC
    Spencer, FA
    Gibson, M
    Rush, JE
    Sanderink, G
    Murphy, SA
    Ball, SP
    Antman, EM
    [J]. AMERICAN HEART JOURNAL, 2002, 143 (05) : 753 - 759
  • [4] Blombäck M, 1998, BLOOD COAGUL FIBRIN, V9, P1
  • [5] BRAN G, 1990, THROMB HAEMOSTASIS, V64, P506
  • [6] Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy
    Bremme, K
    van Rooijen, M
    Yu, A
    Blombäck, M
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (02) : 149 - 155
  • [7] DELAYED ELIMINATION OF ENOXAPARINE IN PATIENTS WITH CHRONIC RENAL-INSUFFICIENCY
    CADROY, Y
    POURRAT, J
    BALADRE, MF
    SAIVIN, S
    HOUIN, G
    MONTASTRUC, JL
    VERNIER, I
    BONEU, B
    [J]. THROMBOSIS RESEARCH, 1991, 63 (03) : 385 - 390
  • [8] Correlation of antifactor Xa concentrations with renal function in patients on enoxaparin
    Chow, SL
    Zammit, K
    West, K
    Dannenhoffer, M
    Lopez-Candales, A
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (06) : 586 - 590
  • [9] Collignon F, 1995, THROMB HAEMOSTASIS, V15, P119
  • [10] DOSE ADJUSTED HEPARIN TREATMENT OF DEEP VENOUS THROMBOSIS - A COMPARISON OF UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN
    HANDELAND, GF
    ABILDGAARD, U
    HOLM, HA
    ARNESEN, KE
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (02) : 107 - 112
123